When this 5-LOX deficiency was transferred into a transgenic mouse model of AD, the Tg2576, the amyloid-β deposition in the brains of Tg2576 mice lacking 5-LOX, was reduced by 64%–80% compared with Tg2576 controls [4]. The gene discussed is ALOX5; the disease is Alzheimer disease.